ReSync Bio, Sapio Sciences adopt Nvidia BioNeMo to supercharge AI drug discovery

talkbio0Tagged , , , , , , ,

ReSync Bio and Sapio Sciences Adopt NVIDIA BioNeMo to Accelerate AI-Powered Drug Discovery

Key Details

  • ReSync Bio and Sapio Sciences have integrated NVIDIA's BioNeMo platform into their drug discovery workflows to enhance AI capabilities12.

  • The integrations aim to make advanced AI models more accessible to drug discovery teams without requiring coding expertise12.

  • BioNeMo provides state-of-the-art AI tools tailored for drug discovery, including microservices for tasks like molecular generation and docking predictions110.

ReSync Bio Integration

  • ReSync has integrated NVIDIA's small molecule NIM microservices, including DiffDock, MolMIM, and GenMol10.

  • This allows users to run a full suite of in-silico analysis throughout the drug discovery lifecycle on ReSync's platform10.

  • ReSync's platform enables secure storage of virtual compounds, running of AI models, and tracking of experimental progress10.

Sapio Sciences Integration

  • Sapio has integrated BioNeMo into its Sapio Lab Informatics Platform, specifically the Electronic Lab Notebook (ELN)2.

  • Researchers can access BioNeMo NIM microservices within Sapio ELN for tasks like protein structure prediction and small molecule design/optimization2.

  • The integration aims to streamline workflows and improve decision-making in drug discovery2.

Benefits and Impact

  • The integrations democratize access to advanced AI tools for drug discovery teams of all sizes12.

  • They enable faster, more efficient research workflows without requiring extensive AI/coding expertise1210.

  • The collaborations aim to accelerate drug discovery timelines, reduce development costs, and potentially lead to faster breakthroughs in developing new treatments1210.

By adopting NVIDIA's BioNeMo platform, ReSync Bio and Sapio Sciences are working to make AI-powered drug discovery more accessible and efficient for researchers across the pharmaceutical and biotechnology industries.

Sources:

1. https://developer.nvidia.com/blog/accelerating-drug-discovery-at-receptor-ai-with-nvidia-bionemo-cloud-apis/

2. https://www.sapiosciences.com/news/sapio-sciences-makes-ai-native-drug-discovery-seamless-with-nvidia-bionemo/

10. https://www.biospace.com/press-releases/resync-bio-to-democratize-ai-powered-drug-discovery-with-nvidia-bionemo

Leave a Reply

Your email address will not be published. Required fields are marked *